Integra LifeSciences Holdings Corp Stock
Integra LifeSciences Holdings Corp dominated the market today, gaining €0.40 (3.480%).
Currently there is a rather negative sentiment for Integra LifeSciences Holdings Corp with 1 Buy predictions and 4 Sell predictions..
With a target price of 10 € there is a slightly negative potential of -15.97% for Integra LifeSciences Holdings Corp compared to the current price of 11.9 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
C******** o* t** e**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 3.480% | 5.310% | 12.264% | -48.261% | -43.868% | -77.757% | -75.311% |
| Icu Medical Inc. | 0.000% | 3.306% | 1.626% | -20.886% | -14.966% | -14.966% | -22.360% |
| Bio-Rad Labs Inc. A | 1.740% | -1.966% | -4.673% | -17.189% | -14.263% | -31.823% | -41.201% |
| Neogen Corp. | -2.480% | 13.592% | 4.464% | -51.250% | -51.250% | - | - |
Comments
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $13.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Show more
Ratings data for IART provided by MarketBeat
News
Integra (IART) Q2 Revenue Beats by 5%
Integra LifeSciences (NASDAQ:IART), a medical technology company specializing in neurosurgery, reconstructive, and tissue technologies, released its results for Q2 2025 on July 31, 2025. The most
